Articles

Lipid-based nanoparticles (LNPs) are effective non-viral vectors for delivering messenger RNA products (mRNA), most notably used for vaccine production against the recent SARS-CoV-2 pandemic. In this executive summary, you will discover a robust and high-throughput kit-based analysis of nucleic acids extracted from different mRNA-LNP samples.


CGE-LIF: A Robust and Sensitive Approach for Characterizing mRNAs LNPs

Partnering with a single CDMO can increase speed to market, ensure production capacity and avoid costly-time consuming tech transfers. Learn more inside this eBook.

Advances in the Antibody Drug Development Workflow

Scorpius BioManufacturing discusses the importance of selecting the right CDMO for your next clinical biologic campaign. They cover what attributes are needed through evaluating analytical integration as well as new technologies to look for that will mitigate risk and speed your drug’s manufacturing timelines,


Four Critical Aspects of Clinical Development, Manufacturing, and Analysis for Biologics  CDMO

This white paper summarizes information around chromatography resin variability, providing support for developing robust purification bioprocesses.

QbD - understanding sources of process variability

Automated filling of drug substance into single-use bags help optimize fluid management in terms of accuracy, scalability, flexibility, speed and more.

Automated Filling: Unprecedented flexibility to filling well

At-line Spent Media Analysis using the REBEL to Optimize a CHO mAb Fed-Batch Process

This application note examines the suitability of BioBLU® 0.3c Single-Use Bioreactors and the DASbox Mini Bioreactor System in the long-term expansion of CD4+ T cells. 

All Whitepapers